Weak; SenileNCT07131865
Comparison of the Functional Status, Psychosocial Aspects and Discharge Locations of Geriatric Patients Before and After Inpatient Geriatric Rehabilitation
An observational study of Weak; Senile and Old Age; Debility, run by University of Bern at 1 site in Switzerland.
Trial summary
Due to demographic change in Switzerland, the proportion of older people in the population is expected to increase. It is therefore important that people in old age remain in the best of health and maintain their independence for a long time. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Weak; Senile, Old Age; Debility, Movement Disorders
- How many people
- 753 participants
- Where
- 1 siteSwitzerland
- Study dates
- 1 Jan 2020to 31 Dec 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: Age greater than 65 years Presence of multimorbidity
Who may be able to join
- All patients who were treated as inpatients at the Kliniken Valens Geriatric Rehabilitation according to ICF criteria between 2020 and 2023 will be included.
- Signed the general consent for the further use of their health-related data for research, version 1.2, dated November 18, 2019.
Who cannot join
- No written consent was provided.
Trial locations and contacts
1 site in 1 country.
Switzerland1 site
Kliniken Valens, Rehazentrum Walenstadtberg
Walenstadtberg, St.Gallen, 8881
About this study
Official title: Effectiveness Analysis of Inpatient Geriatric Rehabilitation According to the Valensian Model
Due to demographic change in Switzerland, the proportion of older people in the population is expected to increase. It is therefore important that people in old age remain in the best of health and maintain their independence for a long time.
To this end, the investigators would like to demonstrate the effectiveness of inpatient geriatric rehabilitation at the Valens clinics. This will be done by comparing independence, quality of life, physical and mental health, mobility and hand strength on admission and discharge.
- Conditions
- Weak; Senile, Old Age; Debility, Movement Disorders, Quality of Life, Sarcopenia
- Keywords
- Rehabilitation, Geriatrics, Effectiveness, Frailty
- Medical subject headings
- Asthenia, Frailty, Movement Disorders, Sarcopenia
What is being measured
The primary outcome is the main question the study is designed to answer.
Classification of diagnosis into internal medicine, neurological, or orthopedic/surgical categories
Number of participants with diagnoses are divided into 3 groups: internal medicine, neurology and orthopedic/surgical. The diagnoses are determined and documented at hospital admission based on prior clinical assessments, laboratory results, and imaging studies. They are classified into one of three categories:
Internal medicine (e.g., cardiovascular, respiratory diseases), Neurological (e.g., stroke, neuropathies) or Orthopedic/surgical (e.g., fractures, joint disorders). This classification reflects the patient's primary diagnosis at the time of study enrollment.
Measured: At baseline (upon hospital admission and study enrollment)
Cumulative Health Rating Scale (CIRS)
The Cumulative Illness Rating Scale is a tool used to measure the overall burden of chronic illnesses across multiple organ systems. Each system is rated from 0 (no problem) to 4 (severe problem), and the scores are added up to reflect a patient's total morbidity. It is commonly used in geriatrics to assess multimorbidity and help predict health outcomes.
Measured: At baseline (upon hospital admission and study enrollment)
Functional Independence Measure (FIM)
The FIM assesses how independently a person can perform daily activities. It uses an 18-item scale covering motor and cognitive tasks, each rated from 1 (total assistance needed) to 7 (complete independence). The total score reflects the level of disability and the amount of assistance required for daily living. Higher scores mean greater independence.
Measured: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days
Health-related quality of life (EQ5D-5VAS)
The EQ-5D-5VAS is a brief, standardized questionnaire for measuring health-related quality of life. It consists of two parts Descriptive system: Assesses five dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression-each with five levels of severity, allowing patients to describe their health state precisely and Visual Analogue Scale (VAS): Patients rate their overall health on a scale from 0 (worst imaginable health) to 100 (best imaginable health), providing a quantitative self-assessment
Measured: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days
Patient Reported Outcomes Measurement Information System - (PROMIS-10)
It is a short, 10-item questionnaire that measures subjective physical and mental health from the patient's perspective. It covers areas like physical function, pain, fatigue, emotional distress and social health. It helps researchers understand how the patients are feeling in terms of both body and mind.
Higher scores indicate better health.
Measured: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days
Timed Up and Go Test (TUG)
The Timed Up and Go (TUG) test is a simple test for assessing mobility and balance. The person stands up from a chair, walks three meters, turns around, walks back, and sits down again. The time required to complete the task is measured.
Measured: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days
Grip strength measured by the Jamar Hand Dynamometer
The Jamar Hand Dynamometer is a standardized instrument used to measure grip strength, which reflects the maximum force exerted by the hand muscles during a squeeze.
The grip strength is an important functional outcome and indicator of overall muscle strength and physical health. It is a reliable, non-invasive, and easy-to-administer test that provides valuable information about the participant's muscular strength and functional status.
Participants will be asked to squeeze the dynamometer handle with maximum effort for a few seconds. The device will record the force applied, reported in kilograms.
Measured: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days
Secondary outcomes (5)
Age of participants
Participant age will be recorded in years at the time of study enrollment. Age is an important demographic variable used to characterize the study population and to analyze outcomes by age groups if applicable.
Measured: At baseline (upon hospital admission and study enrollment)
Gender of participants
Participant gender will be recorded as male, female, or other at the time of study enrollment. Gender is a key demographic variable to describe the study population and analyze potential differences in outcomes.
Measured: At baseline (upon hospital admission and study enrollment)
Marital status of participants
Marital status will be recorded at the time of study enrollment and categorized as single, married, divorced, widowed, or other. This demographic information helps to characterize the study population and may be used to analyze its influence on health outcomes.
Measured: At baseline (upon hospital admission and study enrollment)
Place of residence of participants
Participants' place of residence will be recorded at the time of study enrollment. This information may include urban or rural status, region, or postal code. It helps to describe the study population and assess potential geographic influences on health outcomes.
Measured: At baseline (upon hospital admission and study enrollment)
Length of hospital stay
The length of hospital stay will be recorded in days, calculated from the date of admission to the date of discharge. This measure reflects the duration of inpatient treatment and may be used to evaluate resource utilization and recovery time.
Measured: From the beginning of the study (at hospitalization and admission to the study) until discharge from the clinic after a stay of approx. 21 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Aug 2025
- Study start1 Jan 2020
- Primary completion31 Dec 2023
- Study completion31 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Weak; SenileStudies of the same condition, open and under way.
- More trials run by University of BernThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 753 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Bern
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Prof. Dr. Stefan Bachmann, Prof. Dr. med., Study chair, University of Bern, Kliniken Valens
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07131865
- Sponsor's protocol ID
- 2025-00382
- Other IDs
- EKOS 25/028, 2025
- Status last verified
- Aug 2025
- First submitted
- 12 Aug 2025
- Last updated
- 20 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness Analysis of Inpatient Geriatric Rehabilitation According to the Valensian Model
- ClinicalTrials.gov ID
- NCT07131865
- Acronym / sponsor ID
- 2025-00382
- Conditions
- Weak; Senile, Old Age; Debility, Movement Disorders, Quality of Life, Sarcopenia
- Keywords
- Rehabilitation, Geriatrics, Effectiveness, Frailty
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 753 participants (actual)
- Lead sponsor
- University of BernUniversity, hospital or other
- Study start
- 1 Jan 2020 (actual)
- Primary completion
- 31 Dec 2023 (actual)
- Study completion
- 31 Dec 2023 (actual)
- First posted
- 20 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Due to demographic change in Switzerland, the proportion of older people in the population is expected to increase. It is therefore important that people in old age remain in the best of health and maintain their independence for a long time.
To this end, the investigators would like to demonstrate the effectiveness of inpatient geriatric rehabilitation at the Valens clinics. This will be done by comparing independence, quality of life, physical and mental health, mobility and hand strength on admission and discharge.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- Age greater than 65 years Presence of multimorbidity
Key inclusion criteria (2 listed)
- All patients who were treated as inpatients at the Kliniken Valens Geriatric Rehabilitation according to ICF criteria between 2020 and 2023 will be included.
- Signed the general consent for the further use of their health-related data for research, version 1.2, dated November 18, 2019.
Key exclusion criteria (1 listed)
- No written consent was provided.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Classification of diagnosis into internal medicine, neurological, or orthopedic/surgical categories
Time frame: At baseline (upon hospital admission and study enrollment)
Number of participants with diagnoses are divided into 3 groups: internal medicine, neurology and orthopedic/surgical. The diagnoses are determined and documented at hospital admission based on prior clinical assessments, laboratory results, and imaging studies. They are classified into one of three categories: Internal medicine (e.g., cardiovascular, respiratory diseases), Neurological (e.g., stroke, neuropathies) or Orthopedic/surgical (e.g., fractures, joint disorders). This classification reflects the patient's primary diagnosis at the time of study enrollment.
Cumulative Health Rating Scale (CIRS)
Time frame: At baseline (upon hospital admission and study enrollment)
The Cumulative Illness Rating Scale is a tool used to measure the overall burden of chronic illnesses across multiple organ systems. Each system is rated from 0 (no problem) to 4 (severe problem), and the scores are added up to reflect a patient's total morbidity. It is commonly used in geriatrics to assess multimorbidity and help predict health outcomes.
Functional Independence Measure (FIM)
Time frame: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days
The FIM assesses how independently a person can perform daily activities. It uses an 18-item scale covering motor and cognitive tasks, each rated from 1 (total assistance needed) to 7 (complete independence). The total score reflects the level of disability and the amount of assistance required for daily living. Higher scores mean greater independence.
Health-related quality of life (EQ5D-5VAS)
Time frame: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days
The EQ-5D-5VAS is a brief, standardized questionnaire for measuring health-related quality of life. It consists of two parts Descriptive system: Assesses five dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression-each with five levels of severity, allowing patients to describe their health state precisely and Visual Analogue Scale (VAS): Patients rate their overall health on a scale from 0 (worst imaginable health) to 100 (best imaginable health), providing a quantitative self-assessment
Patient Reported Outcomes Measurement Information System - (PROMIS-10)
Time frame: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days
It is a short, 10-item questionnaire that measures subjective physical and mental health from the patient's perspective. It covers areas like physical function, pain, fatigue, emotional distress and social health. It helps researchers understand how the patients are feeling in terms of both body and mind. Higher scores indicate better health.
Timed Up and Go Test (TUG)
Time frame: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days
The Timed Up and Go (TUG) test is a simple test for assessing mobility and balance. The person stands up from a chair, walks three meters, turns around, walks back, and sits down again. The time required to complete the task is measured.
Grip strength measured by the Jamar Hand Dynamometer
Time frame: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days
The Jamar Hand Dynamometer is a standardized instrument used to measure grip strength, which reflects the maximum force exerted by the hand muscles during a squeeze. The grip strength is an important functional outcome and indicator of overall muscle strength and physical health. It is a reliable, non-invasive, and easy-to-administer test that provides valuable information about the participant's muscular strength and functional status. Participants will be asked to squeeze the dynamometer handle with maximum effort for a few seconds. The device will record the force applied, reported in kilograms.
5 secondary outcomes
Age of participants
Time frame: At baseline (upon hospital admission and study enrollment)
Gender of participants
Time frame: At baseline (upon hospital admission and study enrollment)
Marital status of participants
Time frame: At baseline (upon hospital admission and study enrollment)
Place of residence of participants
Time frame: At baseline (upon hospital admission and study enrollment)
Length of hospital stay
Time frame: From the beginning of the study (at hospitalization and admission to the study) until discharge from the clinic after a stay of approx. 21 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Aug 2025.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Prof. Dr. Stefan Bachmann, Prof. Dr. med. study chair
University of Bern, Kliniken Valens
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Weak; Senile and Old Age; Debility, run by University of Bern at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Classification of diagnosis into internal medicine, neurological, or orthopedic/surgical categories (time frame: At baseline (upon hospital admission and study enrollment)). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2025.